Clinical Trials Browser

Suspended × Interventional × Standard of Care × Clear all

NCT07025538 2026-02-23

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Phase 1 Suspended

Hematopoietic and Lymphatic System Neoplasm

NCT03568292 2025-11-17

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

Phase NA Suspended

Neoplasms